FIELD: medicine.
SUBSTANCE: an immunity-inducing composition that expresses SCD1 in a mamma and comprises a polypeptide or recombinant vector that contains a polynucleotide encoding the polypeptide as an effective ingredient is administered. The polypeptide consists of an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 2, SEQ ID NO: 22 and SEQ ID NO: 24. The recombinant vector is capable of expressing the said polypeptide in vivo. Also a method in vitro preparation of an antigen-presenting cell and an in vitro method for preparation of a cytotoxic T-cell are proposed.
EFFECT: treatment and prevention of malignant neoplasm.
6 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNITY-INDUCING MEANS | 2012 |
|
RU2614386C2 |
| IMMUNITY INDUCING AGENT | 2009 |
|
RU2511039C2 |
| IMMUNITY INDUCING AGENT | 2013 |
|
RU2639518C2 |
| IMMUNE-INDUCING AGENT | 2017 |
|
RU2733841C2 |
| IMMUNITY INDUCER | 2017 |
|
RU2755542C2 |
| MEDICATION FOR IMMUNITY INDUCTION AND METHOD OF MALIGNANT TUMOUR IDENTIFICATION | 2009 |
|
RU2519675C2 |
| CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME | 2009 |
|
RU2502740C2 |
| SPARC-DERIVATIVE ANTIGENIC PEPTIDES CAUSING TUMOUR REJECTION AND MEDICATIONS CONTAINING SUCH PEPTIDES | 2007 |
|
RU2451521C2 |
| TEM8 PEPTIDES AND VACCINES CONTAINING THEM | 2008 |
|
RU2498993C2 |
| IMMUNITY INDUCER | 2016 |
|
RU2758112C2 |
